ARLINGTON, Va. — In the growing effort to achieve pro-patient and pro-pharmacy reforms of direct and indirect remuneration (DIR) fees in Medicare Part D, the National Association of Chain Drug Stores today hailed a letter to Health and Human Services Secretary Alex Azar signed by 50 members of the U.S. House of Representatives and led
Direct and indirect remuneration (DIR) is one component of the complex Medicare Part D payment system. In the past several months, the issue of DIR increasingly has become a source of contention between various players in the Part D program. Pharmacies, the Centers for Medicare and Medicaid Services (CMS), and members of Congress have expressed
ALEXANDRIA, Va. — The National Community Pharmacists Association has called on Congress to hold hearings on legislation that would crack down on direct and indirect remuneration (DIR) fees. NCPA said it has sent letters to the chair and ranking member of the Senate Finance Committee and to the chair and ranking members of the House
WASHINGTON — Reps. Morgan Griffith (R., Va.) and Peter Welch (D., Vt.) have reintroduced the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 1038), which community pharmacies say would squelch a growing burden: retroactive direct and indirect remuneration (DIR) fees. The bill, introduced Wednesday in the House of Representatives, would ban the application
